Total planned funding: $119,901,220
Allocations
Countries/Regions
Ukraine | $119,901,220 |
Organizational Types
Private Contractor | $32,428,578 |
Unknown | $28,342,532 |
NGO | $19,899,498 |
Own Agency | $13,544,519 |
Multi-lateral Agency | $11,788,586 |
Other USG Agency | $4,875,507 |
University | $4,850,000 |
Implementing Agency | $4,172,000 |
Program Areas
Governance and Systems | $51,009,513 |
Treatment | $23,001,222 |
Prevention | $17,076,800 |
Care | $9,748,837 |
Testing | $9,614,400 |
Management and Operations | $9,450,448 |
Budget Codes
OHSS: Health Systems Strengthening | $27,384,979 |
HVSI: Strategic Information | $13,427,530 |
HTXS: Treatment: Adult Treatment | $11,595,932 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HLAB: Laboratory Infrastructure | $10,197,004 |
HVCT: Testing: HIV Testing and Counseling | $9,614,400 |
HVMS: Management and Operations | $9,450,448 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,620,854 |
HVTB: Care: TB/HIV | $6,153,368 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,095,299 |
HMBL: Biomedical Prevention: Blood Safety | $2,892,694 |
HKID: Care: Orphans and Vulnerable Children | $1,909,128 |
HBHC: Care: Adult Care and Support | $1,686,341 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $174,596 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$28,342,532
Countries/Regions
Chemonics International:
$17,939,470
Countries/Regions
USG Aggregated Agencies:
$10,992,932
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions